Desmoplastic Small Round Cell Tumor  >>  imatinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
imatinib / Generic mfg.
NCT00417807 / 2005-001614-41: Imatinib Mesylate in Patients With Refractory Desmoplastic Small Round Cell Tumors

Completed
1/2
9
Europe
Imatinib mesilate, STI571
Novartis Pharmaceuticals
Refractory Desmoplastic Small Round Cell Tumors
06/09
 

Download Options